Products

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

Press Release CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19. EUROIMMUN today announced the launch of the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2, the pathogen causing COVID-19. The CE marked assay adds […]

Science

The accursed clinical eye

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 4th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany According to Professor Hans Rieth, the unforgotten master of mycological entertainment, the clinical eye is often a relative of the evil eye. He described the problem of

Company

Oncgnostics and EUROIMMUN Announce Collaboration to Distribute Cervical Cancer Test GynTect

Press Release Jena / Lübeck (GER) – Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN Medizinische Labordiagnostika AG. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect, in the European countries of Portugal, Italy, Turkey and Poland. The test is also expected

Science

A feeling of Sherlock Holmes

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 3rd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany The marvellous city of Edinburgh inspired several novelists such as Joanne K. Rowling (“Harry Potter” and Robert Louis Stevenson (“The strange case of Dr Jekyll and Mr

Science

Up to the last spore

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 2nd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Professor Seebacher, a leading dermatomycologist, always warned us never to end onychomycosis therapy too early. Here are the reasons: Mycosis does not confer immunity. But, above all,

Scroll to Top